世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Platelet Rich Plasma (PRP)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Platelet Rich Plasma (PRP) was estimated to be worth US$ 364 million in 2024 and is forecast to a readjusted size of US$ 758 million by 2031 with a CAGR of 11.2% during the fo... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global market for Platelet Rich Plasma (PRP) was estimated to be worth US$ 364 million in 2024 and is forecast to a readjusted size of US$ 758 million by 2031 with a CAGR of 11.2% during the forecast period 2025-2031.Platelet Rich Plasma is a biologic isolated from whole blood that is preferentially enriched for platelets. While platelets are the primary component of PRP, preparations may also contain other cellular components such as white blood cells (WBCs) and peripheral stem cells. These components all play a biological role in the healing process and are provided at concentrated levels in PRP. Thus, PRP may help optimize the conditions for healing of bone and soft tissue. Global Platelet Rich Plasma key players include Harvest Technologies, DePuy Synthes, Stryker, Zimmer Biomet, etc. Global top four manufacturers hold a share about 75%. North America is the largest market, with a share about 55%, followed by Asia-Pacific and Europe, both have a share over 40 percent. In terms of product, P-PRP is the largest segment, with a share over 60%. And in terms of application, the largest application is Orthopedic Surgery, followed by Cosmetic Surgery, General Surgery, etc. This report aims to provide a comprehensive presentation of the global market for Platelet Rich Plasma (PRP), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Platelet Rich Plasma (PRP) by region & country, by Type, and by Application. The Platelet Rich Plasma (PRP) market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platelet Rich Plasma (PRP). Market Segmentation By Company Harvest Technologies DePuy Synthes Stryker Zimmer Biomet Arthrex Exactech Emcyte Corporation Arteriocyte Adilyfe Segment by Type P-PRP L-PRP L-PRF Segment by Application Orthopedic Surgery Cosmetic Surgery General Surgery Other Surgeries By Region North America United States Canada Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia-Pacific Europe Germany France U.K. Italy Netherlands Nordic Countries Rest of Europe Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Chapter Outline Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 2: Detailed analysis of Platelet Rich Plasma (PRP) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Sales, revenue of Platelet Rich Plasma (PRP) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world. Chapter 6: Sales, revenue of Platelet Rich Plasma (PRP) in country level. It provides sigmate data by Type, and by Application for each country/region. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 9: Conclusion. Table of Contents1 Market Overview1.1 Platelet Rich Plasma (PRP) Product Introduction 1.2 Global Platelet Rich Plasma (PRP) Market Size Forecast 1.2.1 Global Platelet Rich Plasma (PRP) Sales Value (2020-2031) 1.2.2 Global Platelet Rich Plasma (PRP) Sales Volume (2020-2031) 1.2.3 Global Platelet Rich Plasma (PRP) Sales Price (2020-2031) 1.3 Platelet Rich Plasma (PRP) Market Trends & Drivers 1.3.1 Platelet Rich Plasma (PRP) Industry Trends 1.3.2 Platelet Rich Plasma (PRP) Market Drivers & Opportunity 1.3.3 Platelet Rich Plasma (PRP) Market Challenges 1.3.4 Platelet Rich Plasma (PRP) Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Platelet Rich Plasma (PRP) Players Revenue Ranking (2024) 2.2 Global Platelet Rich Plasma (PRP) Revenue by Company (2020-2025) 2.3 Global Platelet Rich Plasma (PRP) Players Sales Volume Ranking (2024) 2.4 Global Platelet Rich Plasma (PRP) Sales Volume by Company Players (2020-2025) 2.5 Global Platelet Rich Plasma (PRP) Average Price by Company (2020-2025) 2.6 Key Manufacturers Platelet Rich Plasma (PRP) Manufacturing Base and Headquarters 2.7 Key Manufacturers Platelet Rich Plasma (PRP) Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of Platelet Rich Plasma (PRP) 2.9 Platelet Rich Plasma (PRP) Market Competitive Analysis 2.9.1 Platelet Rich Plasma (PRP) Market Concentration Rate (2020-2025) 2.9.2 Global 5 and 10 Largest Manufacturers by Platelet Rich Plasma (PRP) Revenue in 2024 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Platelet Rich Plasma (PRP) as of 2024) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 P-PRP 3.1.2 L-PRP 3.1.3 L-PRF 3.2 Global Platelet Rich Plasma (PRP) Sales Value by Type 3.2.1 Global Platelet Rich Plasma (PRP) Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Platelet Rich Plasma (PRP) Sales Value, by Type (2020-2031) 3.2.3 Global Platelet Rich Plasma (PRP) Sales Value, by Type (%) (2020-2031) 3.3 Global Platelet Rich Plasma (PRP) Sales Volume by Type 3.3.1 Global Platelet Rich Plasma (PRP) Sales Volume by Type (2020 VS 2024 VS 2031) 3.3.2 Global Platelet Rich Plasma (PRP) Sales Volume, by Type (2020-2031) 3.3.3 Global Platelet Rich Plasma (PRP) Sales Volume, by Type (%) (2020-2031) 3.4 Global Platelet Rich Plasma (PRP) Average Price by Type (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Orthopedic Surgery 4.1.2 Cosmetic Surgery 4.1.3 General Surgery 4.1.4 Other Surgeries 4.2 Global Platelet Rich Plasma (PRP) Sales Value by Application 4.2.1 Global Platelet Rich Plasma (PRP) Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Platelet Rich Plasma (PRP) Sales Value, by Application (2020-2031) 4.2.3 Global Platelet Rich Plasma (PRP) Sales Value, by Application (%) (2020-2031) 4.3 Global Platelet Rich Plasma (PRP) Sales Volume by Application 4.3.1 Global Platelet Rich Plasma (PRP) Sales Volume by Application (2020 VS 2024 VS 2031) 4.3.2 Global Platelet Rich Plasma (PRP) Sales Volume, by Application (2020-2031) 4.3.3 Global Platelet Rich Plasma (PRP) Sales Volume, by Application (%) (2020-2031) 4.4 Global Platelet Rich Plasma (PRP) Average Price by Application (2020-2031) 5 Segmentation by Region 5.1 Global Platelet Rich Plasma (PRP) Sales Value by Region 5.1.1 Global Platelet Rich Plasma (PRP) Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Platelet Rich Plasma (PRP) Sales Value by Region (2020-2025) 5.1.3 Global Platelet Rich Plasma (PRP) Sales Value by Region (2026-2031) 5.1.4 Global Platelet Rich Plasma (PRP) Sales Value by Region (%), (2020-2031) 5.2 Global Platelet Rich Plasma (PRP) Sales Volume by Region 5.2.1 Global Platelet Rich Plasma (PRP) Sales Volume by Region: 2020 VS 2024 VS 2031 5.2.2 Global Platelet Rich Plasma (PRP) Sales Volume by Region (2020-2025) 5.2.3 Global Platelet Rich Plasma (PRP) Sales Volume by Region (2026-2031) 5.2.4 Global Platelet Rich Plasma (PRP) Sales Volume by Region (%), (2020-2031) 5.3 Global Platelet Rich Plasma (PRP) Average Price by Region (2020-2031) 5.4 North America 5.4.1 North America Platelet Rich Plasma (PRP) Sales Value, 2020-2031 5.4.2 North America Platelet Rich Plasma (PRP) Sales Value by Country (%), 2024 VS 2031 5.5 Europe 5.5.1 Europe Platelet Rich Plasma (PRP) Sales Value, 2020-2031 5.5.2 Europe Platelet Rich Plasma (PRP) Sales Value by Country (%), 2024 VS 2031 5.6 Asia Pacific 5.6.1 Asia Pacific Platelet Rich Plasma (PRP) Sales Value, 2020-2031 5.6.2 Asia Pacific Platelet Rich Plasma (PRP) Sales Value by Region (%), 2024 VS 2031 5.7 South America 5.7.1 South America Platelet Rich Plasma (PRP) Sales Value, 2020-2031 5.7.2 South America Platelet Rich Plasma (PRP) Sales Value by Country (%), 2024 VS 2031 5.8 Middle East & Africa 5.8.1 Middle East & Africa Platelet Rich Plasma (PRP) Sales Value, 2020-2031 5.8.2 Middle East & Africa Platelet Rich Plasma (PRP) Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Platelet Rich Plasma (PRP) Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Platelet Rich Plasma (PRP) Sales Value 6.2.1 Key Countries/Regions Platelet Rich Plasma (PRP) Sales Value, 2020-2031 6.2.2 Key Countries/Regions Platelet Rich Plasma (PRP) Sales Volume, 2020-2031 6.3 United States 6.3.1 United States Platelet Rich Plasma (PRP) Sales Value, 2020-2031 6.3.2 United States Platelet Rich Plasma (PRP) Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Platelet Rich Plasma (PRP) Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Platelet Rich Plasma (PRP) Sales Value, 2020-2031 6.4.2 Europe Platelet Rich Plasma (PRP) Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Platelet Rich Plasma (PRP) Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Platelet Rich Plasma (PRP) Sales Value, 2020-2031 6.5.2 China Platelet Rich Plasma (PRP) Sales Value by Type (%), 2024 VS 2031 6.5.3 China Platelet Rich Plasma (PRP) Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Platelet Rich Plasma (PRP) Sales Value, 2020-2031 6.6.2 Japan Platelet Rich Plasma (PRP) Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Platelet Rich Plasma (PRP) Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Platelet Rich Plasma (PRP) Sales Value, 2020-2031 6.7.2 South Korea Platelet Rich Plasma (PRP) Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Platelet Rich Plasma (PRP) Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Platelet Rich Plasma (PRP) Sales Value, 2020-2031 6.8.2 Southeast Asia Platelet Rich Plasma (PRP) Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Platelet Rich Plasma (PRP) Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Platelet Rich Plasma (PRP) Sales Value, 2020-2031 6.9.2 India Platelet Rich Plasma (PRP) Sales Value by Type (%), 2024 VS 2031 6.9.3 India Platelet Rich Plasma (PRP) Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 Harvest Technologies 7.1.1 Harvest Technologies Company Information 7.1.2 Harvest Technologies Introduction and Business Overview 7.1.3 Harvest Technologies Platelet Rich Plasma (PRP) Sales, Revenue, Price and Gross Margin (2020-2025) 7.1.4 Harvest Technologies Platelet Rich Plasma (PRP) Product Offerings 7.1.5 Harvest Technologies Recent Development 7.2 DePuy Synthes 7.2.1 DePuy Synthes Company Information 7.2.2 DePuy Synthes Introduction and Business Overview 7.2.3 DePuy Synthes Platelet Rich Plasma (PRP) Sales, Revenue, Price and Gross Margin (2020-2025) 7.2.4 DePuy Synthes Platelet Rich Plasma (PRP) Product Offerings 7.2.5 DePuy Synthes Recent Development 7.3 Stryker 7.3.1 Stryker Company Information 7.3.2 Stryker Introduction and Business Overview 7.3.3 Stryker Platelet Rich Plasma (PRP) Sales, Revenue, Price and Gross Margin (2020-2025) 7.3.4 Stryker Platelet Rich Plasma (PRP) Product Offerings 7.3.5 Stryker Recent Development 7.4 Zimmer Biomet 7.4.1 Zimmer Biomet Company Information 7.4.2 Zimmer Biomet Introduction and Business Overview 7.4.3 Zimmer Biomet Platelet Rich Plasma (PRP) Sales, Revenue, Price and Gross Margin (2020-2025) 7.4.4 Zimmer Biomet Platelet Rich Plasma (PRP) Product Offerings 7.4.5 Zimmer Biomet Recent Development 7.5 Arthrex 7.5.1 Arthrex Company Information 7.5.2 Arthrex Introduction and Business Overview 7.5.3 Arthrex Platelet Rich Plasma (PRP) Sales, Revenue, Price and Gross Margin (2020-2025) 7.5.4 Arthrex Platelet Rich Plasma (PRP) Product Offerings 7.5.5 Arthrex Recent Development 7.6 Exactech 7.6.1 Exactech Company Information 7.6.2 Exactech Introduction and Business Overview 7.6.3 Exactech Platelet Rich Plasma (PRP) Sales, Revenue, Price and Gross Margin (2020-2025) 7.6.4 Exactech Platelet Rich Plasma (PRP) Product Offerings 7.6.5 Exactech Recent Development 7.7 Emcyte Corporation 7.7.1 Emcyte Corporation Company Information 7.7.2 Emcyte Corporation Introduction and Business Overview 7.7.3 Emcyte Corporation Platelet Rich Plasma (PRP) Sales, Revenue, Price and Gross Margin (2020-2025) 7.7.4 Emcyte Corporation Platelet Rich Plasma (PRP) Product Offerings 7.7.5 Emcyte Corporation Recent Development 7.8 Arteriocyte 7.8.1 Arteriocyte Company Information 7.8.2 Arteriocyte Introduction and Business Overview 7.8.3 Arteriocyte Platelet Rich Plasma (PRP) Sales, Revenue, Price and Gross Margin (2020-2025) 7.8.4 Arteriocyte Platelet Rich Plasma (PRP) Product Offerings 7.8.5 Arteriocyte Recent Development 7.9 Adilyfe 7.9.1 Adilyfe Company Information 7.9.2 Adilyfe Introduction and Business Overview 7.9.3 Adilyfe Platelet Rich Plasma (PRP) Sales, Revenue, Price and Gross Margin (2020-2025) 7.9.4 Adilyfe Platelet Rich Plasma (PRP) Product Offerings 7.9.5 Adilyfe Recent Development 8 Industry Chain Analysis 8.1 Platelet Rich Plasma (PRP) Industrial Chain 8.2 Platelet Rich Plasma (PRP) Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Platelet Rich Plasma (PRP) Sales Model 8.5.2 Sales Channel 8.5.3 Platelet Rich Plasma (PRP) Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療/ヘルスケア）の最新刊レポート
QYResearch社の医薬・ヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD（plasma）の最新刊レポートよくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
